$19.64
0.31.53%
At close: -
$19.63
-0.0050-0.03%
After Hours: 4:02 PM EDT
Comments
Loading...
Contineum Therapeutics (NASDAQ:CTNM) Stock, Earnings Estimates, EPS, And Revenue
Contineum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 6
EPS
$-0.400
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Contineum Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Contineum Therapeutics (CTNM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-06 | $-0.40 | $-0.43 | 6.98 % |
| Jun 2024 | 2024-08-13 | $-0.39 | $-0.35 | -11.4 % |
Contineum Therapeutics (CTNM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?
Contineum Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for Contineum Therapeutics (NASDAQ:CTNM)?
Contineum Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $-0.40, which beat the estimate of $-0.43.
What were Contineum Therapeutics’s (NASDAQ:CTNM) revenues?
Contineum Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.